NEUROVIVE Trademark

Trademark Overview

On Friday, September 7, 2007, a trademark application was filed for NEUROVIVE with the United States Patent and Trademark Office. The USPTO has given the NEUROVIVE trademark a serial number of 79047227. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, May 24, 2019. This trademark is owned by NeuroPharma I Sverige AB. The NEUROVIVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for the treatment and prevention of acute and chronic neurological illnesses and conditions; Medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, namely, for brain damage and for use in brain operations and other physical and neurological ailments of the brain; Medicines and pharmaceutical preparations for use in the area of neurological intensive care; Medicines and pharmaceutical preparations for use as immunosuppressive agents in organ transplants or other medical and clinical uses of immunosuppressive agents and preparations
neurovive

General Information

Serial Number79047227
Word MarkNEUROVIVE
Filing DateFriday, September 7, 2007
Status709 - CANCELLED - SECTION 71
Status DateFriday, May 24, 2019
Registration Number3520893
Registration DateTuesday, October 21, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 5, 2008

Trademark Statements

Goods and ServicesPharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for the treatment and prevention of acute and chronic neurological illnesses and conditions; Medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, namely, for brain damage and for use in brain operations and other physical and neurological ailments of the brain; Medicines and pharmaceutical preparations for use in the area of neurological intensive care; Medicines and pharmaceutical preparations for use as immunosuppressive agents in organ transplants or other medical and clinical uses of immunosuppressive agents and preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 24, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbliva AB
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSE
Party NameNeuroPharma I Sverige AB
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSE
Party NameNeuroPharma I Sverige AB
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSE

Trademark Events

Event DateEvent Description
Sunday, January 1, 2023NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, October 27, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, October 23, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, March 20, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Friday, February 21, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, February 21, 2020INVALIDATION PROCESSED
Friday, January 24, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, May 24, 2019CANCELLED SECTION 71
Monday, November 12, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 12, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, October 21, 2017COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, September 28, 2017INTERNATIONAL REGISTRATION RENEWED
Thursday, May 7, 2015NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Thursday, May 7, 2015REGISTERED-SEC.71 ACCEPTED
Thursday, May 7, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 21, 2015TEAS SECTION 71 RECEIVED
Saturday, September 28, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, January 7, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, February 4, 2009FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, February 4, 2009FINAL DISPOSITION PROCESSED
Thursday, January 22, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 21, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, August 5, 2008PUBLISHED FOR OPPOSITION
Wednesday, July 16, 2008NOTICE OF PUBLICATION
Monday, June 30, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 30, 2008ASSIGNED TO LIE
Sunday, June 29, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 13, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 13, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 13, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 13, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 13, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 1, 2008REFUSAL PROCESSED BY IB
Thursday, January 10, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 10, 2008REFUSAL PROCESSED BY MPU
Thursday, January 10, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, January 9, 2008NON-FINAL ACTION WRITTEN
Monday, December 31, 2007ASSIGNED TO EXAMINER
Monday, December 31, 2007NEW APPLICATION ENTERED IN TRAM
Friday, December 28, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

neurovive preparations pharmaceutical medicines brain neurological agents namely immunosuppressive other treatment